Dr Agarwal’s targets 60 new centres by March 2027; Fortis plans 1,700+ beds
Jefferies highlights healthcare expansion as a key growth driver: Dr Agarwal’s Healthcare aims to take its India network to about 350 centres, while Fortis Healthcare plans roughly 400 beds in FY27 and more than 1,700 over four to five years.
What happened
Emcure Pharmaceuticals · Jefferies named Emcure, Fortis, Dr Agarwal’s and Gland Pharma as Indian healthcare SMID picks, citing earnings growth, capacity
Key facts
- Emcure target price Rs 2,100; 26% upside
- Fortis target price Rs 1,125; 24% upside
- Dr Agarwal’s target price Rs 1,150; 18% upside
- Gland target price Rs 3,350; 17% upside
- Fortis plans about 400 beds in FY27 and over 1,700 beds in four to five years
- Dr Agarwal’s plans 60 new centres by March 2027, taking India network to about 350
- Expected EBITDA growth for the four companies: 16-23% in FY27
Why this matters
The expansion plans raise competitive pressure for premium locations, specialist talent and regional partnerships, while creating opportunities for acquisition, lease and ecosystem deals that accelerate capacity build-out.
What to watch
- Quarterly net centre additions by Dr Agarwal’s and bed commissioning versus stated targets.
- Occupancy, average revenue per occupied bed, surgery volumes and same-store revenue trends.
- EBITDA margin movement during the new-facility ramp period.
- Doctor, nurse and technician attrition or compensation inflation.
- Capital-expenditure guidance, debt levels and any equity fundraising or acquisition announcements.
- Regulatory approvals, land or lease transactions, and announced city-level expansion clusters.
- Accelerate recruitment and retention programs for ophthalmologists, surgeons, nurses and hospital operations staff.
- Prioritize brownfield acquisitions, leased facilities and cluster expansion to shorten time-to-revenue.
- Increase spending on diagnostics, surgical equipment, digital appointment systems and referral-network development.
- Use newly added capacity to expand high-acuity, elective and premium-care offerings.
- Strengthen insurer, corporate and government-payer relationships to support faster bed and centre utilization.